List of Master Control Manufacturing Execution Simplified Customers
Salt Lake, 84121, UT,
United States
Since 2010, our global team of researchers has been studying Master Control Manufacturing Execution Simplified customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Master Control Manufacturing Execution Simplified for Manufacturing Execution System from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Master Control Manufacturing Execution Simplified for Manufacturing Execution System include: Carestream Health, a United States based Healthcare organisation with 4400 employees and revenues of $1.90 billion, Almac Group, a United Kingdom based Life Sciences organisation with 7500 employees and revenues of $1.00 billion, Quva Pharma, a United States based Life Sciences organisation with 110 employees and revenues of $12.0 million and many others.
Contact us if you need a completed and verified list of companies using Master Control Manufacturing Execution Simplified, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Master Control Manufacturing Execution Simplified customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Almac Group | Life Sciences | 7500 | $1.0B | United Kingdom | MasterControl | Master Control Manufacturing Execution Simplified | Manufacturing Execution System | 2021 | n/a |
Almac Group implemented Master Control Manufacturing Execution Simplified in 2021 at Almac Sciences in Craigavon, Northern Ireland. The deployment used Master Control Manufacturing Execution Simplified as a Manufacturing Execution System to introduce electronic batch records and to orchestrate batch-level production and quality workflows for peptide and personalized-medicine manufacturing campaigns.
The implementation centered on electronic batch records, structured batch review workflows, and audit-trail instrumentation, leveraging Manufacturing Execution System functionality for production tracking, quality documentation, and controlled review cycles. Master Control Manufacturing Execution Simplified was configured to digitalize batch documentation and to standardize reviewer handoffs and audit documentation consistent with good manufacturing practice requirements.
Operational coverage was focused on Almac Sciences manufacturing and quality assurance functions in Craigavon, affecting batch release, QA review, and regulatory audit readiness. Governance activity emphasized configuration of batch review workflows and documentation controls, and public materials associate the project timeline with MasterControl coverage in 2022 so the 2021 to 2022 dates are estimates based on that public material; case study reporting highlights faster production cycles and improved audit readiness following the move from paper batch records to electronic batch records.
|
 |
Carestream Health | Healthcare | 4400 | $1.9B | United States | MasterControl | Master Control Manufacturing Execution Simplified | Manufacturing Execution System | 2020 | n/a |
In 2020, Carestream Health implemented Master Control Manufacturing Execution Simplified, a Manufacturing Execution System, across its global manufacturing footprint. The initial deployment concentrated on standardizing digital work instructions and instituting electronic device history record workflows to improve data consistency and accelerate review processes.
Master Control Manufacturing Execution Simplified was configured to centralize eDHR creation and review, enforce structured data entry controls to reduce input errors, and deliver standardized digital work instructions across multiple sites. Functional capabilities implemented included eDHR management, digital work instruction orchestration, role-based data segregation, and automated review routing, reflecting standard Manufacturing Execution System workflows for regulated device production.
Operational coverage extended to Carestream’s global manufacturing sites, affecting manufacturing, quality, and regulatory business functions and consolidating cross-site data visibility. Governance and process changes established standardized review workflows and site-level data segregation to support compliance and faster electronic DHR review cycles. According to MasterControl case materials the 2020 implementation produced measured outcomes of reduced data-input errors, faster eDHR creation and review, and improved cross-site data segregation.
|
 |
Quva Pharma | Life Sciences | 110 | $12M | United States | MasterControl | Master Control Manufacturing Execution Simplified | Manufacturing Execution System | 2020 | n/a |
In 2020 QuVa Pharma deployed Master Control Manufacturing Execution Simplified as its Manufacturing Execution System to digitize lab and manufacturing workflows for its 503B sterile compounding operations in the United States. The implementation centralized electronic records and integrated quality and testing processes to create faster, more integrated procedures across laboratory and production functions during the COVID 19 pandemic.
Master Control Manufacturing Execution Simplified was configured to manage electronic records and structured testing workflows, aligning quality testing steps with production handoffs. The deployment leveraged Manufacturing Execution System capabilities typical for regulated pharma operations, including electronic recordkeeping, test result capture, enforced workflow sequencing and controls that support right first time checks across lab and manufacturing activities.
Operational coverage encompassed QuVa Pharma laboratory, manufacturing and quality teams supporting 503B sterile compounding, with the MES governing documentation, test evidence and release related activities for U S operations. The rollout required adapting processes and training during pandemic conditions, and governance focused on embedding controlled workflows and audit capable electronic records to support compliance demands.
According to the case study the 2020 implementation delivered faster, more integrated processes and improved throughput and right first time metrics for QuVa Pharma’s 503B sterile compounding operations.
|
Buyer Intent: Companies Evaluating Master Control Manufacturing Execution Simplified
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||